Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule

Area of Science:

• Immunology
• Vaccinology
• Pediatrics

Background:

• Infant immunization is crucial for preventing infectious diseases.
• Polio remains a global health concern, necessitating effective vaccination strategies.
• Early immune responses in newborns can differ from older individuals.

Purpose of the Study:

• To evaluate the immunogenicity of an enhanced potency inactivated polio vaccine (IPV) in healthy newborns.
• To assess the development of neutralizing antibody (NA) responses after primary and secondary IPV doses.
• To investigate the potential for inducing immunologic memory in early infancy.

Main Methods:

• 141 healthy newborns received an initial dose of enhanced IPV within 24 hours of birth.
• A second IPV dose was administered at six months of age.
• Neutralizing antibody titers were measured to assess immune response.
• A supplementary IPV dose was given to infants with low antibody levels after the second dose.

Main Results:

• A significant proportion of infants developed neutralizing antibodies (NA) after the second IPV dose.
• The rapid antibody rise indicated an anamnestic response, suggesting pre-existing immunologic memory.
• Infants with low NA after two doses showed a robust response to a supplementary dose.

Conclusions:

• Enhanced potency IPV administered at birth can induce immunologic memory in newborns.
• This early immunologic memory may offer a basis for protection against wild poliovirus exposure later in life.
• Early infant immunization with IPV is a promising strategy for long-term polio prevention.